Patel, D., John, J., Bodepudi, R., Seher, S., Khan, S., Emmanuel, S., Shantha, V., Nerella, R., Shaman, B., & Hamid, P. (2024). Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes. Journal For International Medical Graduates, 3(1). https://doi.org/10.56570/jimgs.v1i1.149